Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver Cirrhosis
1 other identifier
observational
50
1 country
1
Brief Summary
the study aims to evaluate the role of similar technology of Narrow Band Imaging VIST video intelligent staining technology in the diagnosis of Gastric Antral Vascular ectasia in cirrhotic patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2019
CompletedFirst Submitted
Initial submission to the registry
May 11, 2020
CompletedFirst Posted
Study publicly available on registry
May 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 21, 2022
March 1, 2022
1.1 years
May 11, 2020
March 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of Narrow Band Spectrum endoscopy for the diagnosis of Gastric antral vascular ectasia in cirrhotic patients
It is done by the new technology of VIST which is similar to Narrow Band Imaging in the diagnosis of Gastric antral vascular ectasia in cirrhotic patients that were misdiagnosed before as portal hypertension gastropathy
it is estimated to be 12 months
Interventions
Gastroscope with technology of VIST video intelligent staining technology for taking biopsies
Eligibility Criteria
The study population includes all cirrhotic patients undergoing Upper gastrointestinal endoscopy and they have antral erosions by endoscopy
You may qualify if:
- Patients with mucosal vascular lesions at the gastric antrum suspicious of GAVE of a linear striped form or a diffuse punctate form upon conventional WLE
You may not qualify if:
- Connective tissue disorders like systemic sclerosis.
- Chronic kidney disease.
- Recent use of proton pump inhibitors in the last 14 days.
- History of gastric surgery or gastric cancer.
- Pernicious anemia.
- Recent history of non-steroidal anti-inflammatory drugs intake
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Internal Medicine, Hepatology Unit. Faculty of Medicine, Alexandria University
Alexandria, Egypt
Biospecimen
biopsies
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randa Salah Eldin Abdelmoneim, Master
Alexandria University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer, Internal Medicine Department
Study Record Dates
First Submitted
May 11, 2020
First Posted
May 14, 2020
Study Start
November 11, 2019
Primary Completion
December 31, 2020
Study Completion
March 1, 2021
Last Updated
March 21, 2022
Record last verified: 2022-03